Survodutide

Telomere biology, gene regulation, circadian biology, and aging research

Nine-amino-acid peptide

Investigational; limited modern controlled human evidence

Overview

Survodutide (BI 456906) is an investigational dual agonist designed to activate both GLP-1 and glucagon receptors. The GLP-1 component targets incretin, appetite, and glucose-regulation pathways, while glucagon-receptor activity is being studied for effects on energy expenditure and hepatic lipid metabolism. Human clinical programs have evaluated obesity and metabolic dysfunction-associated steatohepatitis/liver-fat outcomes. It remains a clinical-development compound.

How it works

checkCreated with Sketch.

GLP-1 receptor signaling: Influences satiety, glucose-dependent insulin signaling, and gastrointestinal pathways.

checkCreated with Sketch.

Glucagon receptor signaling: Research investigates energy expenditure, lipid oxidation, and hepatic metabolism.

checkCreated with Sketch.

Dual-pathway integration: The compound is designed to balance two receptor systems for complementary metabolic effects.

Research areas

checkCreated with Sketch.

Obesity research

checkCreated with Sketch.

Metabolic liver disease

checkCreated with Sketch.

Hepatic fat metabolism

checkCreated with Sketch.

Glycemic and cardiometabolic endpoints

Research / study context

one

Phase 2 obesity research: Human trials evaluated body-weight change, metabolic markers, tolerability, and dose-response.

two

MASH/liver research: Randomized trials have evaluated liver histology, liver fat, fibrosis-related endpoints, and metabolic outcomes.

Key research findings

checkCreated with Sketch.

Clinical studies demonstrate strong biologic activity in obesity and liver-metabolism endpoints.

checkCreated with Sketch.

Gastrointestinal adverse effects are common in GLP-1-based research.

checkCreated with Sketch.

Survodutide remains investigational and should not be presented as an approved therapy.

Scientific reference starter set

one

Peptide Education Hub: Survodutide profile

two

PubMed search: survodutide BI 456906 obesity

three

ClinicalTrials.gov search: survodutide MASH obesity

Research material

View available specifications and batch documentation in the Apex catalog.

Important

For research use only. Not for human consumption. This profile is educational and does not provide treatment or personal-use instructions.